| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 331 | 17.051 | 16.476 | 19.380 | 28.507 | 46.051 | 40.971 | 46.747 | 49.209 |
| Total Income - EUR | - | 331 | 17.052 | 16.478 | 19.382 | 28.518 | 46.059 | 40.992 | 49.219 | 49.340 |
| Total Expenses - EUR | - | 1.396 | 8.851 | 10.505 | 10.657 | 11.007 | 11.185 | 21.054 | 31.525 | 31.515 |
| Gross Profit/Loss - EUR | - | -1.065 | 8.201 | 5.973 | 8.725 | 17.511 | 34.874 | 19.938 | 17.694 | 17.825 |
| Net Profit/Loss - EUR | - | -1.072 | 8.030 | 5.808 | 8.531 | 17.242 | 34.469 | 19.590 | 17.292 | 17.390 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Vialormed Vet 2016 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 22.899 | 20.914 | 18.892 |
| Current Assets | - | 167 | 7.428 | 13.191 | 9.504 | 22.921 | 54.989 | 48.942 | 57.301 | 67.626 |
| Inventories | - | 9 | 477 | 137 | 86 | 254 | 713 | 716 | 0 | 302 |
| Receivables | - | 0 | 405 | 2 | 6.136 | 2.067 | 5.428 | 355 | 202 | 5.729 |
| Cash | - | 158 | 6.547 | 13.052 | 3.281 | 20.600 | 48.848 | 47.871 | 57.099 | 61.595 |
| Shareholders Funds | - | -1.027 | 7.020 | 12.699 | 8.574 | 19.664 | 53.696 | 67.370 | 76.548 | 84.884 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.194 | 408 | 491 | 931 | 3.257 | 722 | 3.898 | 1.666 | 1.634 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vialormed Vet 2016 S.r.l.